1. Merck and Sanofi both buying smaller cancer oncology companies at big premiums — The latest from ASH2019 conference — Biopharma Dive’s drug launch of the year: Zolgensma — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

BioHorizons

Anonymous board for BioHorizons


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    2
    Views:
    2,210
  2. anonymous
    Replies:
    1
    Views:
    1,590
  3. anonymous
    Replies:
    1
    Views:
    3,183
  4. anonymous
    Replies:
    25
    Views:
    7,658
  5. anonymous
    Replies:
    1
    Views:
    4,204
  6. anonymous
    Replies:
    4
    Views:
    2,689
  7. Anonymous
    Replies:
    3
    Views:
    4,228
  8. Anonymous
    Replies:
    28
    Views:
    15,330
  9. Anonymous
    Replies:
    37
    Views:
    12,066
  10. Anonymous
    Replies:
    14
    Views:
    3,898
  11. Anonymous
    Replies:
    51
    Views:
    17,804
  12. Anonymous
    Replies:
    11
    Views:
    4,689
  13. Anonymous
    Replies:
    0
    Views:
    2,482
  14. Anonymous
    Replies:
    37
    Views:
    12,389
  15. Anonymous
    Replies:
    22
    Views:
    5,370
  16. Anonymous
    Replies:
    3
    Views:
    2,796
  17. Anonymous
    Replies:
    6
    Views:
    3,934
  18. Anonymous
    Replies:
    85
    Views:
    28,636

Thread Display Options

Loading...